Michael Drazer, MD, PhD, is a hematologist/oncologist and geneticist specializing in the care of people with blood disorders, blood cancers, hereditary blood disorders, and hereditary cancer syndromes. He runs one of the only clinics in the world focused on the care of people with hereditary blood cancer syndromes. 
 
Dr. Drazer's laboratory research focuses on determining the mechanisms that drive hereditary blood and cancer syndromes, with a particular emphasis on developing "high fidelity" cellular and mouse models of these disorders. He is also heavily involved in the discovery of novel hereditary blood and cancer syndromes. His clinical research is largely focused on optimizing the care of people with hereditary blood and cancer syndromes, including the development of clinical bioinformatics pipelines that improve the diagnosis of patients with these syndromes. He is a member of multiple clinical disease groups at the University of Chicago. 
 
An active researcher, Dr. Drazer's work has been featured in journals such as Blood, Blood Advances, Journal of Clinical Oncology, JAMA, Haematologica, Leukemia, Cancer, Stem Cell Reports, and Genetics in Medicine. His work has been supported by the Damon Runyon Cancer Research Foundation, the Edward P. Evans Foundation, the Cancer Research Foundation, the National Heart, Lung, and Blood Institute, and the National Cancer Institute. 
 
Dr. Drazer is also actively involved in the training of 21 hematology/oncology fellows within the Department of Medicine.